This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
4 Chemical Stocks Poised to Outshine Q2 Earnings Estimates
by Zacks Equity Research
Chemical makers are seeing strong demand from the construction and automotive sectors.
Sinopec, Albemarle Ink Non-Binding Accord for Hydrocracking
by Zacks Equity Research
Sinopec's (SNP) subsidiaries and Albemarle will develop effective solutions for heavy feedstock hydrocracking for the global refining industry.
Albemarle (ALB) Down 6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Albemarle (ALB) Stock a Solid Choice Right Now?
by Zacks Equity Research
Albemarle (ALB) could be an interesting play for investors as it is seeing solid earnings estimate revision in addition to having a robust industry rank.
Here's Why You Should Add Albemarle (ALB) to Your Portfolio
by Zacks Equity Research
Strong fundamentals and compelling growth prospects make Albemarle (ALB) an attractive choice for investment.
Albemarle (ALB) Q1 Earnings Top Estimates on Lithium Strength
by Zacks Equity Research
Strong performance of the Lithium segment drove Albemarle's (ALB) Q1 results.
Will Lithium Unit Help Albemarle (ALB) Beat Earnings in Q1?
by Zacks Equity Research
Strong momentum in Albemarle's (ALB) core lithium business is likely to continue in Q1.
Albemarle Closes Sale of Part of Performance Catalysts Unit
by Zacks Equity Research
Albemarle (ALB) closes the sale of its polyolefin catalysts and components business to W. R. Grace & Co. for around $416 million.
Should Value Investors Pick Albemarle (ALB) Stock Now?
by Zacks Equity Research
Let's put Albemarle Corporation (ALB) stock into this equation and find out if it is a good choice for value-oriented investors right now.
Albemarle (ALB) Down 16.3% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights: DowDuPont, Albemarle and Monsanto
by Zacks Equity Research
Zacks Industry Outlook Highlights: DowDuPont, Albemarle and Monsanto
Albemarle Gets Nod for Increase in Lithium Quota in Chile
by Zacks Equity Research
The lithium quota increase for Chile operations will enable Albemarle (ALB) to boost capacity in a highly sustainable and efficient manner using innovative technology.
Albemarle's (ALB) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Strong segment performance drove Albemarle's (ALB) results in Q4.
Why Lithium ETF Plunged to Start the Week?
by Zacks Equity Research
Lithium ETF plunges as Morgan Stanley issues report introducing fears of a demand supply gap for lithium.
Albemarle (ALB) Announces 5% Hike in Quarterly Dividend
by Zacks Equity Research
Albemarle's (ALB) latest move marks its quarterly dividend hike for the 24th consecutive year.
Can Albemarle (ALB) Beat Q4 Earnings on Lithium Strength?
by Zacks Equity Research
Strong momentum in Albemarle's (ALB) core Lithium and Advanced Materials unit is likely to continue in Q4.
Albemarle (ALB) Stock Up 25% in 6 Months: Here's Why
by Zacks Equity Research
Upbeat outlook for 2017 and strategic growth initiatives have contributed to a rally in Albemarle's (ALB) shares.
Albemarle Launches Granite Technology, Boosts FCC Portfolio
by Zacks Equity Research
Albemarle's (ALB) latest move expands its FCC product portfolio.
Albemarle to Sell Portion of Performance Catalysts Unit
by Zacks Equity Research
Albemarle (ALB) inks deal with Grace to divest a portion of its Performance Catalysts Solutions business for roughly $416 million.
The Zacks Analyst Blog Highlights: Kronos Worldwide, Westlake Chemical, Kraton, Albemarle and Celanese
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Kronos Worldwide, Westlake Chemical, Kraton, Albemarle and Celanese
U.S. Chemical Industry Set to Ride High: 5 Stocks for 2018
by Zacks Equity Research
As the U.S. chemical industry's upturn is expected to continue in 2018, it would be a prudent idea to invest in chemical stocks with compelling growth prospects.
Albemarle (ALB) Down 9.6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Albemarle (ALB) reported earnings more than 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Albemarle (ALB) Shares Up 48% YTD: What's Driving the Stock?
by Zacks Equity Research
Forecast-topping earnings performance and an upbeat outlook have contributed to a rally in Albemarle's (ALB) shares.
Chemical Industry Recovers from Hurricanes, October Output Up
by Zacks Equity Research
Global chemical production rose 0.4% in October on gains across all chemical producing regions.
Kraton Corp (KRA) Up 46% in 3 Months: What's Driving It?
by Zacks Equity Research
Strong third-quarter 2017 results and upbeat prospects have contributed to a rally in Kraton's (KRA) shares.